title: Experience in optimizing fertility outcomes in men with congenital adrenal hyperplasia due to 21 hydroxylase deficiency.
abstract: Men with congenital adrenal hyperplasia (CAH) have impaired fertility. We aimed to assess fertility outcomes and the importance of hypogonadotropic hypogonadism, testicular failure and the presence of testicular adrenal rest tumours (TART).
  
  
  
  Retrospective analysis of men attending an adult CAH clinic in a tertiary centre.
  
  
  
  Fifty men with CAH due to 21 hydroxylase deficiency were identified of whom 35 were salt wasting and 15 were non-salt-wasting.
  
  
  
  Review of fertility history and parameters including luteinizing hormone (LH), follicle-stimulating hormone (FSH), androstenedione, 17-hydroxyprogesterone (17-OHP), semen analysis and the presence of testicular adrenal rest tissue (TART) on ultrasound.
  
  
  
  TART were detected by ultrasound in 21 (47%), and their presence was associated with an elevated FSH (P = 0·01). Severe oligospermia was present in 11 of 23 (48%), and this was associated with an elevated FSH (P = 0·02), suppressed LH (P < 0·01) and TART (P = 0·03) when compared to those with a sperm count >5 × 10(6) per ml. Of those that desired fertility, 10 of 17 (59%) required treatment intensification and four underwent in vitro fertilization. Intensification resulted in a rise in median LH (0·6-4·3 IU/l; P = 0·01). Live birth rate was 15 of 17 (88%) with a median (range) time to conception of 8 (0-38) months.
  
  
  
  Suppressed LH is a marker for subfertility and is often reversible. Testicular failure is closely associated with TART formation. If TART are detected, sperm cryopreservation should be offered given the risk of progression to irreversible testicular failure. Male fertility in CAH can be improved by intensified treatment and assisted reproductive technology.
authors.affiliation: Department of Endocrinology, University College London Hospitals, London, UK.|Institute for Women's Health, University College London Hospitals, London, UK.
authors.forename: Thomas F J
authors.identifier: 0000-0002-0383-3433
authors.initials: TF
authors.lastname: King
authors.affiliation: Department of Endocrinology, University College London Hospitals, London, UK.|Institute for Women's Health, University College London Hospitals, London, UK.
authors.forename: Marilyn Cheng
authors.initials: MC
authors.lastname: Lee
authors.affiliation: Institute for Women's Health, University College London Hospitals, London, UK.
authors.forename: Elizabeth E J
authors.initials: EE
authors.lastname: Williamson
authors.affiliation: Department of Endocrinology, University College London Hospitals, London, UK.|Institute for Women's Health, University College London Hospitals, London, UK.
authors.forename: Gerard S
authors.initials: GS
authors.lastname: Conway
mesh_terms: D000293:Adolescent; D000312:Adrenal Hyperplasia, Congenital / Q000150:complications*; D000314:Adrenal Rest Tumor / Q000000981:diagnostic imaging; D000328:Adult; D005640:Follicle Stimulating Hormone / Q000032:analysis; D006801:Humans; D007248:Infertility, Male / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy*; D007986:Luteinizing Hormone / Q000032:analysis; D008297:Male; D008875:Middle Aged; D027724:Reproductive Techniques, Assisted; D012189:Retrospective Studies; D055101:Semen Analysis; D013736:Testicular Neoplasms / Q000000981:diagnostic imaging; D016896:Treatment Outcome; D014463:Ultrasonography; D055815:Young Adult
chemical_list: D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone